RT Journal Article
SR Electronic
T1 Influence of social determinants of health and county vaccination rates on machine learning models to predict COVID-19 case growth in Tennessee
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.28.21260814
DO 10.1101/2021.07.28.21260814
A1 Wylezinski, Lukasz S.
A1 Harris, Coleman R.
A1 Heiser, Cody N.
A1 Gray, Jamieson D.
A1 Spurlock, Charles F.
YR 2021
UL http://medrxiv.org/content/early/2021/07/30/2021.07.28.21260814.abstract
AB The SARS-CoV-2 (COVID-19) pandemic has exposed health disparities throughout the United States, particularly among racial and ethnic minorities. As a result, there is a need for data-driven approaches to pinpoint the unique constellation of clinical and social determinants of health (SDOH) risk factors that give rise to poor patient outcomes following infection in US communities.We combined county-level COVID-19 testing data, COVID-19 vaccination rates, and SDOH information in Tennessee. Between February-May 2021, we trained machine learning models on a semi-monthly basis using these datasets to predict COVID-19 incidence in Tennessee counties. We then analyzed SDOH data features at each time point to rank the impact of each feature on model performance.Our results indicate that COVID-19 vaccination rates play a crucial role in determining future COVID-19 disease risk. Beginning in mid-March 2021, higher vaccination rates significantly correlated with lower COVID-19 case growth predictions. Further, as the relative importance of COVID-19 vaccination data features grew, demographic SDOH features such as age, race, and ethnicity decreased while the impact of socioeconomic and environmental factors, including access to healthcare and transportation, increased.Incorporating a data framework to track the evolving patterns of community-level SDOH risk factors could provide policymakers with additional data resources to improve health equity and resilience to future public health emergencies.Competing Interest StatementAuthors Wylezinski, Gray and Spurlock are shareholders in IQuity Labs, Inc. (Nashville, TN) and Decode Health, Inc. (Nashville, TN). IQuity Labs develops blood-based tools using RNA to aid in the diagnosis and treatment of human disease. Decode Health develops artificial intelligence approaches to predict chronic and infectious disease risk in patient populations.Funding StatementThis work was supported by Decode Health, Inc., IQuity Labs, Inc., and grants from the National Institutes of Health (AI124766, AI129147 and AI145505).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB approval was not necessary. Data to support the study were available from publicly available sources as outlined in the materials and methods.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author upon reasonable request.